Pharmaceuticals, Biotechnology and Life Sciences
BLA submission includes both myelodysplastic syndromes and beta-thalassemia indications EMA marketing application for both indications planned for Q2:19 SUMMIT, N.J.…
Trovagene said that additional data from its ongoing Phase 1b/2 study of onvansertib combined with standard-of-care chemotherapy in Acute Myeloid…
DUBLIN–(BUSINESS WIRE)–The “Juvenile Macular Degeneration (Stargardt Disease) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.…
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on therapeutics for human aging, announced today…
DUBLIN–(BUSINESS WIRE)–The “Crigler-Najjar Syndrome – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Crigler-Najjar Syndrome –…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today…
BOSTON–(BUSINESS WIRE)–Jnana Therapeutics today announced the appointment of Donald Nicholson, Ph.D., an accomplished scientist and executive, as chair of its…
Mallinckrodt’s retrospective study has shown the effectiveness of Extracorporeal Photopheresis (ECP), as an adjunct to local standard therapy, in lung transplant recipients with Bronchiolitis Obliterans Syndrome (BOS).
DUBLIN–(BUSINESS WIRE)–The “Global Healthcare Logistics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The healthcare logistics market will register…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today…